Rifampicin can induce antibiotic tolerance in mycobacteria via paradoxical changes in rpoB transcription
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Rifampicin can induce antibiotic tolerance in mycobacteria via paradoxical changes in rpoB transcription
Authors
Keywords
-
Journal
Nature Communications
Volume 9, Issue 1, Pages -
Publisher
Springer Nature America, Inc
Online
2018-10-05
DOI
10.1038/s41467-018-06667-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Fidaxomicin jams Mycobacterium tuberculosis RNA polymerase motions needed for initiation via RbpA contacts
- (2018) Hande Boyaci et al. eLife
- Posttranslational modification of a histone-like protein regulates phenotypic resistance to isoniazid in mycobacteria
- (2018) Alexandra Sakatos et al. Science Advances
- Finding the right dose of rifampicin, and the right dose of optimism
- (2017) Rovina Ruslami et al. LANCET INFECTIOUS DISEASES
- High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial
- (2017) Martin J Boeree et al. LANCET INFECTIOUS DISEASES
- Deletion of a mycobacterial divisome factor collapses single-cell phenotypic heterogeneity
- (2017) E. Hesper Rego et al. NATURE
- Rifamycin action on RNA polymerase in antibiotic-tolerantMycobacterium tuberculosisresults in differentially detectable populations
- (2017) Kohta Saito et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antibiotic tolerance facilitates the evolution of resistance
- (2017) Irit Levin-Reisman et al. SCIENCE
- A temporal proteome dynamics study reveals the molecular basis of induced phenotypic resistance in Mycobacterium smegmatis at sub-lethal rifampicin concentrations
- (2017) Alexander D. Giddey et al. Scientific Reports
- Evaluation of high-dose rifampin in patients with new, smear-positive tuberculosis (HIRIF): study protocol for a randomized controlled trial
- (2016) Meredith Milstein et al. BMC INFECTIOUS DISEASES
- Drug Concentration Thresholds Predictive of Therapy Failure and Death in Children With Tuberculosis: Bread Crumb Trails in Random Forests
- (2016) Soumya Swaminathan et al. CLINICAL INFECTIOUS DISEASES
- Intensified Antituberculosis Therapy in Adults with Tuberculous Meningitis
- (2016) A. Dorothee Heemskerk et al. NEW ENGLAND JOURNAL OF MEDICINE
- Temporal and intrinsic factors of rifampicin tolerance in mycobacteria
- (2016) Kirill Richardson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The essential mycobacterial amidotransferase GatCAB is a modulator of specific translational fidelity
- (2016) Hong-Wei Su et al. Nature Microbiology
- Transcriptional Adaptation of Drug-tolerantMycobacterium tuberculosisDuring Treatment of Human Tuberculosis
- (2015) Nicholas D. Walter et al. JOURNAL OF INFECTIOUS DISEASES
- The association between sterilizing activity and drug distribution into tuberculosis lesions
- (2015) Brendan Prideaux et al. NATURE MEDICINE
- Classic reaction kinetics can explain complex patterns of antibiotic action
- (2015) Pia Abel zur Wiesch et al. Science Translational Medicine
- Leaderless Transcripts and Small Proteins Are Common Features of the Mycobacterial Translational Landscape
- (2015) Scarlet S. Shell et al. PLoS Genetics
- Novel diagnostics and therapeutics for drug-resistant tuberculosis
- (2014) M. Toosky et al. BRITISH MEDICAL BULLETIN
- Molecular Mechanisms Underlying Bacterial Persisters
- (2014) Etienne Maisonneuve et al. CELL
- Optimization of lag time underlies antibiotic tolerance in evolved bacterial populations
- (2014) Ofer Fridman et al. NATURE
- Mycobacterial mistranslation is necessary and sufficient for rifampicin phenotypic resistance
- (2014) B. Javid et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Internalization of Salmonella by Macrophages Induces Formation of Nonreplicating Persisters
- (2014) S. Helaine et al. SCIENCE
- Simultaneous determination of rifampicin, clarithromycin and their metabolites in dried blood spots using LC–MS/MS
- (2014) D.H. Vu et al. TALANTA
- Opposing effects of target overexpression reveal drug mechanisms
- (2014) Adam C. Palmer et al. Nature Communications
- Isocitrate lyase mediates broad antibiotic tolerance in Mycobacterium tuberculosis
- (2014) Madhumitha Nandakumar et al. Nature Communications
- Serum Drug Concentrations Predictive of Pulmonary Tuberculosis Outcomes
- (2013) J. G. Pasipanodya et al. JOURNAL OF INFECTIOUS DISEASES
- Activated ClpP kills persisters and eradicates a chronic biofilm infection
- (2013) B. P. Conlon et al. NATURE
- Mycobacterium tuberculosis mutation rate estimates from different lineages predict substantial differences in the emergence of drug-resistant tuberculosis
- (2013) Christopher B Ford et al. NATURE GENETICS
- Advances in the development of new tuberculosis drugs and treatment regimens
- (2013) Alimuddin Zumla et al. NATURE REVIEWS DRUG DISCOVERY
- A problem of persistence: still more questions than answers?
- (2013) Nathalie Q. Balaban et al. NATURE REVIEWS MICROBIOLOGY
- Separate mechanisms are involved in rifampicin upmodulated and downmodulated gene expression in Salmonella Typhimurium
- (2013) Grace Yim et al. RESEARCH IN MICROBIOLOGY
- Dynamic Persistence of Antibiotic-Stressed Mycobacteria
- (2013) Y. Wakamoto et al. SCIENCE
- Genome-wide Mapping of Transcriptional Start Sites Defines an Extensive Leaderless Transcriptome in Mycobacterium tuberculosis
- (2013) Teresa Cortes et al. Cell Reports
- Interaction of CarD with RNA Polymerase Mediates Mycobacterium tuberculosis Viability, Rifampin Resistance, and Pathogenesis
- (2012) L. A. Weiss et al. JOURNAL OF BACTERIOLOGY
- Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an open-label, randomised controlled phase 2 trial
- (2012) Rovina Ruslami et al. LANCET INFECTIOUS DISEASES
- Fiji: an open-source platform for biological-image analysis
- (2012) Johannes Schindelin et al. NATURE METHODS
- Mycobacterium tuberculosis RbpA protein is a new type of transcriptional activator that stabilizes the σ A -containing RNA polymerase holoenzyme
- (2012) Yangbo Hu et al. NUCLEIC ACIDS RESEARCH
- High-resolution transcriptome and genome-wide dynamics of RNA polymerase and NusA in Mycobacterium tuberculosis
- (2012) Swapna Uplekar et al. NUCLEIC ACIDS RESEARCH
- Fresh Approaches to Anti-Infective Therapies
- (2012) C. Nathan Science Translational Medicine
- Drug Tolerance in Replicating Mycobacteria Mediated by a Macrophage-Induced Efflux Mechanism
- (2011) Kristin N. Adams et al. CELL
- Creeping baselines and adaptive resistance to antibiotics
- (2011) Lucía Fernández et al. DRUG RESISTANCE UPDATES
- Asymmetry and Aging of Mycobacterial Cells Lead to Variable Growth and Antibiotic Susceptibility
- (2011) B. B. Aldridge et al. SCIENCE
- Metabolic Regulation of Mycobacterial Growth and Antibiotic Sensitivity
- (2011) Seung-Hun Baek et al. PLOS BIOLOGY
- Persister Cells
- (2010) Kim Lewis Annual Review of Microbiology
- Taking phage integration to the next level as a genetic tool for mycobacteria
- (2010) Jason Huff et al. GENE
- Emergence of Pseudomonas aeruginosa Strains Producing High Levels of Persister Cells in Patients with Cystic Fibrosis
- (2010) L. R. Mulcahy et al. JOURNAL OF BACTERIOLOGY
- Protein inactivation in mycobacteria by controlled proteolysis and its application to deplete the beta subunit of RNA polymerase
- (2010) Jee-Hyun Kim et al. NUCLEIC ACIDS RESEARCH
- Enzymatic assembly of DNA molecules up to several hundred kilobases
- (2009) Daniel G Gibson et al. NATURE METHODS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started